PortViewPortView
Stereotaxis logo

Stereotaxis (STXS) Stock Analysis

AMEXHealthcareMedical - Instruments & Supplies

$1.41+2.55%
1-year price historyRange $1.26 – $3.57
52-week range$1.41
$1.24$3.59

What Stereotaxis does

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Key metrics

Market cap
$137.60M
P/E (TTM)
-8.26
EPS (TTM)
$-0.17
Beta
1.40
Dividend yield
0.00%
Revenue / share
$0.30
50-day avg
$1.51
200-day avg
$1.96
52-week high
$3.59
52-week low
$1.24
CEO
David L. Fischel

ETFs linked to STXS

Broad-market and Healthcare sector ETFs an investor holding Stereotaxis is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how STXS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze STXS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Stereotaxis?
Stereotaxis trades under the ticker STXS on AMEX.
Which exchange is STXS listed on?
STXS is listed on AMEX.
What sector does Stereotaxis operate in?
Stereotaxis is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze STXS in a portfolio?
PortView shows STXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.